Sernova Corp. (TSE:SVA – Get Free Report) reached a new 52-week low during trading on Monday . The stock traded as low as C$0.19 and last traded at C$0.19, with a volume of 36501 shares trading hands. The stock had previously closed at C$0.20.
Sernova Price Performance
The stock has a market cap of C$61.81 million, a P/E ratio of -1.46 and a beta of 1.35. The company has a 50 day simple moving average of C$0.23 and a 200 day simple moving average of C$0.25. The company has a current ratio of 0.32, a quick ratio of 18.11 and a debt-to-equity ratio of 16.55.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
See Also
- Five stocks we like better than Sernova
- Are Penny Stocks a Good Fit for Your Portfolio?
- Sizing Up a New Opportunity for NVIDIA Investors
- What Is WallStreetBets and What Stocks Are They Targeting?
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- The 3 Best Fintech Stocks to Buy Now
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
